Rivaroxaban Market to Witness Steady Growth Through 2036 Amid...

добавлена новая статья Health

2026-07-13 18:34:40 -

Rivaroxaban Market to Witness Steady Growth Through 2036 Amid Rising Prevalence of Cardiovascular Disorders

NEWARK, Del., July 13, 2026 — The global healthcare industry is witnessing continued growth in demand for advanced anticoagulant therapies as cardiovascular diseases, atrial fibrillation, and venous thromboembolism cases increase worldwide. According to Future Market Insights (FMI), the Rivaroxaban Market is projected to grow from USD 96.54 million in 2026 to USD 107.64 million by 2036,...

0 Комментарии 0 Поделились 131 Просмотры 0 предпросмотр